Skip Navigation

Advancing Care for Patients with Liver Disease

Providing the highest level of care through a multidisciplinary approach, our dedicated team conducts research to improve health and advance care for patients with chronic liver disease or liver transplantation.

With a focus on Phase II - III clinical trials, our team of hepatologists, clinical research nurses and coordinators, pharmacists, surgeons and other specialists works together to integrate innovative translational research with evidence-based clinical research, giving patients access to optimal care and therapies.

Our current areas of research include:

  • Autoimmune hepatitis
  • Cirrhosis
  • Hepatocellular carcinoma
  • Liver transplantation
  • Nonalcoholic liver fatty disease (NAFLD)
  • Primary biliary cirrhosis
  • Primary sclerosing cholangitis
  • Value-based care in liver disease
  • Viral hepatitis

Our research team has contributed to:

  • The cure for Hepatitis C
  • Therapy of nonalcoholic fatty liver disease
  • Novel, innovative therapy for primary biliary cholangitis and primary sclerosing cholangitis
  • Developing biomarkers for liver fibrosis
  • Successfully reducing 30- and 90-day readmissions by 50 percent after liver transplant